HCW Biologics (HCWB) Q4 2024 Annual Earnings
HCWB·Reported March 28, 2025·Before market open
HCW Biologics reported Q4 2024 revenue of $394.8K, missed analyst consensus of $7.0M by $6.6M. Diluted EPS came in at $-3.20, missed the $3.60 consensus by $6.80.
Revenue
$394.8Kmissed by $6.6M
Consensus: $7.0MDiluted EPS
$-3.20missed by $6.80
Consensus: $3.60
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about HCW Biologics's Q4 2024 earnings report.
HCW Biologics (HCWB) reported Q4 2024 earnings on March 28, 2025 before market open.
HCW Biologics reported revenue of $394.8K and diluted EPS of $-3.20 for Q4 2024.
Revenue missed the consensus estimate of $7.0M by $6.6M. EPS missed the consensus estimate of $3.60 by $6.80.
You can read the 10-K periodic report (0000950170-25-046724) directly on SEC EDGAR. The filing index links above go to sec.gov.